Introduction:
The concept of dissolution was sown more than century ago in 1897 when Noyes & Whitney studied the dissolution of two sparingly soluble compounds, benzoic acid and lead chloride. The experimental set up was conceptually similar to the modern-day dissolution set up having a cylinder immersed in water held at constant temperature and contents inside rotated at constant speed [1]. The work led to the establishment of basic dissolution equation which is Noyes-Whitney equation. By 1950s the value of dissolution and it’s testing in rate of absorption of dosage form was well understood. Today dissolution is not only used for drug development and quality control to check lot-to-lot consistency but also to check the bioequivalence, as an assistive tool in IVIVC [2], SUPAC, and biowaiver of BCS class I and III drugs [3]. The effectiveness of a formulation inordinately depends on the bioavailability which is the rate and extent of drug in systemic circulation that can be available at the site of action [4]. This can be easily estimated by in-vivo tests which takes in-to account valuable parameters like Cmax and AUC to estimate bioavailability[5]. In-vivo bioavailability estimation is an indispensable part of study in getting approval for New Drug Applications and novel formulations.